Author | Roberts, Andrew W. | dc.contributor.author |
Author | Stilgenbauer, Stephan | dc.contributor.author |
Author | Seymour, John F. | dc.contributor.author |
Author | Huang, David C. S. | dc.contributor.author |
Date of accession | 2018-12-18T07:03:36Z | dc.date.accessioned |
Available in OPARU since | 2018-12-18T07:03:36Z | dc.date.available |
Date of first publication | 2017 | dc.date.issued |
Language | en | dc.language.iso |
Publisher | Universität Ulm | dc.publisher |
Keyword | phase-2 trial | dc.subject |
Keyword | open-label | dc.subject |
Keyword | plus rituximab | dc.subject |
Keyword | subcutaneous alemtuzumab | dc.subject |
Keyword | antitumor-activity | dc.subject |
Keyword | bcl-2 inhibitor | dc.subject |
Keyword | transgenic mice | dc.subject |
Keyword | cell survival | dc.subject |
Keyword | 17p deletion | dc.subject |
Keyword | follow-up | dc.subject |
Dewey Decimal Group | DDC 610 / Medicine & health | dc.subject.ddc |
Title | Venetoclax in Patients with Previously Treated Chronic Lymphocytic Leukemia | dc.title |
Resource type | Wissenschaftlicher Artikel | dc.type |
Institution | UKU. Klinik für Innere Medizin III | uulm.affiliationSpecific |
DCMI Type | Text | uulm.typeDCMI |
Category | Publikationsnachweise | uulm.category |
DOI (external) | 10.1158/1078-0432.CCR-16-0955 | dc.identifier.doiExternal |
Source - Title of source | Clinical Cancer Research | source.title |
Source - Place of publication | American Association for Cancer Research | source.publisher |
Source - Volume | 23 | source.volume |
Source - Issue | 16 | source.issue |
Source - Year | 2017 | source.year |
Source - From page | 4527 | source.fromPage |
Source - To page | 4533 | source.toPage |
Source - ISSN | 1078-0432 | source.identifier.issn |
Source - eISSN | 1557-3265 | source.identifier.eissn |
Open Access | gold_or_bronze | uulm.OA |
Community | Universitätsklinikum Ulm | uulm.community |
WoS | 000407614400001 | uulm.identifier.wos |
Bibliography | uulm | uulm.bibliographie |
DFG project uulm | SFB 1074 / Experimentelle Modelle und klinische Translation bei Leukämien / DFG / 217328187 | uulm.projectDFG |